Prophylactic Antibiotics in Preventing Surgical Site Infection After Hepatobiliary Surgery in High-Resistant Settings

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

About this trial

To analyse the efficacy of different preoperative prophylactic antimicrobial regimens for perioperative infection prevention in patients undergoing hepatobiliary surgery in a high antimicrobial resistance setting.

Eligibility criteria

Qualifiers

Adult patients aged ≥18 years;

Deemed eligible for elective hepatobiliary surgery;

Demonstrated comprehension of the study nature and expressed willingness to comply with trial procedures;

Capable of providing written informed consent.

Disqualifiers

History of β-lactam allergy or hypersensitivity

Uncontrolled preoperative infection;

Current or recent (within the preceding month) systemic corticosteroid administration;

Severe hepatic or renal impairment;

Trial design

Treatments tested in this trial

  • Piperacillin-tazobactam

Treatment groups

378 Participants
are divided into 2 treatment groups